StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX - Free Report) in a report issued on Friday. The firm issued a hold rating on the software maker's stock.
Separately, Stephens lifted their price target on shares of Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a report on Friday, January 31st.
Read Our Latest Research Report on MDRX
Veradigm Stock Up 8.2 %
Shares of NASDAQ:MDRX traded up $0.34 during trading on Friday, reaching $4.49. 2,866 shares of the stock were exchanged, compared to its average volume of 416,270. Veradigm has a 12-month low of $3.80 and a 12-month high of $11.80. The firm's 50-day moving average price is $4.66 and its 200 day moving average price is $7.58.
About Veradigm
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
